About Us

Our Leadership

Dr. Patrick McNeillie leads the systems training for natural language processing in artificial intelligence.

Patrick has been active in basic science and clinical oncology research for more than 10 years with over 30 peer-viewed publications. He has spoken extensively about innovations within cancer treatment and in 2012, he won the Pillsbury Award for Outstanding Oral Presentation in Clinical Medicine.

Patrick accepted a position at IBM as a Post-Doctoral Research Fellow in 2013. While at IBM, he worked alongside its computer scientists in applying IBM Watson’s cognitive technologies to healthcare. Patrick was soon promoted to Chief Physician Researcher of the Medical Sieve Grand Challenge where he was responsible for developing technology for medical image analytics.

In 2015, Patrick transitioned from IBM Research to Watson Genomic Analytics to guide the tech development in identifying the genetic alterations that drive cancer and the therapies that target these dysfunctional proteins. Committed to his unique vision of using AI to improve cancer care, Dr. McNeillie left IBM in 2017 to become a Co-founder and Chief Information Officer of NeuralFrame.

Dr. McNeillie holds a BA, Applied Science – Biology from the University of North Carolina at Chapel Hill and an M.D. from the University of North Carolina at Chapel Hill School of Medicine.

A former Project Manager with IBM’s Watson Health Division, Kevin gained extensive experience with training medical NLP/machine learning models and interfacing with drug development projects. In 2017, Kevin partnered with Dr. Patrick McNeillie to launch NeuralFrame and bring their shared vision of AI in medicine to life. Today, Kevin leads all NeuralFrame’s product development efforts.

Kevin graduated magna cum laude from the University of Pennsylvania with a BA, Chemistry from the College of Arts and Sciences and a BS, Economics and Finance from the Wharton School.

A resident of the NYC metro area, Kevin is an accomplished pianist who enjoys meandering walks with his two dogs, a spirited game of baseball, guiding young adults on college applications and tutoring honor students in advanced mathematics and chemistry.

A serial entrepreneur, Brian Scanlan joined NeuralFrame in 2018 as its CEO with direct oversight of Finance, Operations and Sales.

Formerly the CEO of Mount Hope Capital, Brian led the strategy and management of tech-focused VC and PE opportunities for more than 15 years. Prior to Mount Hope Capital, Brian founded Zai*Net Software, Inc – acquired by Sungard Data Systems in April 2003. Later renamed to Caminus, Brian served as President of the Zai*Net Software subsidiary. After successfully leading the preparation and execution of the Caminus IPO in January 2000, he became the CTO of this NASDAQ-listed energy software company. To this day, Brian remains deeply interested in Green Energy Tech.

Brian has a BS, Finance from the Wharton School at the University of Pennsylvania.

A resident of southern Connecticut, Brian is a heath enthusiast and an active member of his community. Brian also serves as a USA Swimming Official and the Official Family Gardener of Connecticut’s finest tomatoes.